Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis

S. Momtazmanesh, P. Shobeiri, A. Saghazadeh, CE. Teunissen, J. Burman, L. Szalardy, P. Klivenyi, A. Bartos, A. Fernandes, N. Rezaei

. 2021 ; 32 (6) : 573-595. [pub] 20210217

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, metaanalýza, práce podpořená grantem, systematický přehled

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004612
E-zdroje Online Plný text

NLK ProQuest Central od 2013-07-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2013-07-01 do Před 6 měsíci
Psychology Database (ProQuest) od 2013-07-01 do Před 6 měsíci

Odkazy

PubMed 33594840
DOI 10.1515/revneuro-2020-0145
Knihovny.cz E-zdroje

Multiple sclerosis (MS) is a neurodegenerative disease associated with inflammatory demyelination and astroglial activation, with neuronal and axonal damage as the leading factors of disability. We aimed to perform a meta-analysis to determine changes in CSF levels of neuronal and glial biomarkers, including neurofilament light chain (NFL), total tau (t-tau), chitinase-3-like protein 1 (CHI3L1), glial fibrillary acidic protein (GFAP), and S100B in various groups of MS (MS versus controls, clinically isolated syndrome (CIS) versus controls, CIS versus MS, relapsing-remitting MS (RRMS) versus progressive MS (PMS), and MS in relapse versus remission. According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, we included 64 articles in the meta-analysis, including 4071 subjects. For investigation of sources of heterogeneity, subgroup analysis, meta-regression, and sensitivity analysis were conducted. Meta-analyses were performed for comparisons including at least three individual datasets. NFL, GFAP, t-tau, CHI3L1, and S100B were higher in MS and NFL, t-tau, and CHI3L1 were also elevated in CIS patients than controls. CHI3L1 was the only marker with higher levels in MS than CIS. GFAP levels were higher in PMS versus RRMS, and NFL, t-tau, and CHI3L1 did not differ between different subtypes. Only levels of NFL were higher in patients in relapse than remission. Meta-regression showed influence of sex and disease severity on NFL and t-tau levels, respectively and disease duration on both. Added to the role of these biomarkers in determining prognosis and treatment response, to conclude, they may serve in diagnosis of MS and distinguishing different subtypes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004612
003      
CZ-PrNML
005      
20220127145120.0
007      
ta
008      
220113s2021 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1515/revneuro-2020-0145 $2 doi
035    __
$a (PubMed)33594840
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Momtazmanesh, Sara $u School of Medicine, Tehran University of Medical Sciences (TUMS), Children's Medical Center Hospital, Dr. Qarib St., Keshavarz Blvd, Tehran14194, Iran $u Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran $u Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
245    10
$a Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis / $c S. Momtazmanesh, P. Shobeiri, A. Saghazadeh, CE. Teunissen, J. Burman, L. Szalardy, P. Klivenyi, A. Bartos, A. Fernandes, N. Rezaei
520    9_
$a Multiple sclerosis (MS) is a neurodegenerative disease associated with inflammatory demyelination and astroglial activation, with neuronal and axonal damage as the leading factors of disability. We aimed to perform a meta-analysis to determine changes in CSF levels of neuronal and glial biomarkers, including neurofilament light chain (NFL), total tau (t-tau), chitinase-3-like protein 1 (CHI3L1), glial fibrillary acidic protein (GFAP), and S100B in various groups of MS (MS versus controls, clinically isolated syndrome (CIS) versus controls, CIS versus MS, relapsing-remitting MS (RRMS) versus progressive MS (PMS), and MS in relapse versus remission. According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, we included 64 articles in the meta-analysis, including 4071 subjects. For investigation of sources of heterogeneity, subgroup analysis, meta-regression, and sensitivity analysis were conducted. Meta-analyses were performed for comparisons including at least three individual datasets. NFL, GFAP, t-tau, CHI3L1, and S100B were higher in MS and NFL, t-tau, and CHI3L1 were also elevated in CIS patients than controls. CHI3L1 was the only marker with higher levels in MS than CIS. GFAP levels were higher in PMS versus RRMS, and NFL, t-tau, and CHI3L1 did not differ between different subtypes. Only levels of NFL were higher in patients in relapse than remission. Meta-regression showed influence of sex and disease severity on NFL and t-tau levels, respectively and disease duration on both. Added to the role of these biomarkers in determining prognosis and treatment response, to conclude, they may serve in diagnosis of MS and distinguishing different subtypes.
650    _2
$a biologické markery $7 D015415
650    _2
$a lidé $7 D006801
650    12
$a roztroušená skleróza $7 D009103
650    12
$a chronicko-progresivní roztroušená skleróza $7 D020528
650    12
$a neurodegenerativní nemoci $7 D019636
650    _2
$a neuroglie $7 D009457
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a systematický přehled $7 D000078182
700    1_
$a Shobeiri, Parnian $u School of Medicine, Tehran University of Medical Sciences (TUMS), Children's Medical Center Hospital, Dr. Qarib St., Keshavarz Blvd, Tehran14194, Iran $u Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran
700    1_
$a Saghazadeh, Amene $u Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran $u Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Teunissen, Charlotte E $u Neurochemistry Laboratory, Department of Clinical Chemistry, Location VUmc, PK 2 BR 141, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
700    1_
$a Burman, Joachim $u Department of Neuroscience, Uppsala University Hospital, 75185Uppsala, Sweden
700    1_
$a Szalardy, Levente $u Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University of Szeged, Semmelweis u. 6, 6725Szeged, Hungary
700    1_
$a Klivenyi, Peter $u Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center, University of Szeged, Semmelweis u. 6, 6725Szeged, Hungary
700    1_
$a Bartos, Ales $u Department of Neurology, Third Faculty of Medicine, Charles University, Ruska 87, 100 00Prague 10, Czech Republic
700    1_
$a Fernandes, Adelaide $u Department of Pharmacological Sciences and Medicines, Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003Lisbon, Portugal
700    1_
$a Rezaei, Nima $u Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran $u Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran $u Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
773    0_
$w MED00208716 $t Reviews in the neurosciences $x 2191-0200 $g Roč. 32, č. 6 (2021), s. 573-595
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33594840 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145116 $b ABA008
999    __
$a ok $b bmc $g 1751926 $s 1155761
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 32 $c 6 $d 573-595 $e 20210217 $i 2191-0200 $m Reviews in the neurosciences $n Rev Neurosci $x MED00208716
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace